GRMN
71
22
WU
18
-2
DFS
70
5
AME
48
4
FCX
59
-4
DNB
48
-2
MU
35
-8
ICE
53
-2
K
50
3
CHRW
47
5
GILD
56
-2
IVZ
52
-3
FAST
63
2
SYK
60
3
TROW
42
-5
KEY
40
-3
VNO
63
-2
HUM
37
3
AIZ
59
5
NEE
52
-2
GRMN
71
22
WU
18
-2
DFS
70
5
AME
48
4
FCX
59
-4
DNB
48
-2
MU
35
-8
ICE
53
-2
K
50
3
CHRW
47
5
GILD
56
-2
IVZ
52
-3
FAST
63
2
SYK
60
3
TROW
42
-5
KEY
40
-3
VNO
63
-2
HUM
37
3
AIZ
59
5
NEE
52
-2
Financhill
Back

Novo Nordisk AS Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
39

NVO
Novo Nordisk AS

Last Price:
111.96
Seasonality Move:
7.41%
Sell
15

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.72
Seasonality Move:
33.42%
Sell
39
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $113.24. The Score for NVO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.70. The Score for ADAP is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $113.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight buying pressure.

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.33 Sell
Relative Strength Index (14 RSI): 33.23 Sell
Chaikin Money Flow: 9284762 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (113.98 - 120.7) Sell
Bollinger Bands (100): (121.55 - 140.81) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 21.29 Sell
Chaikin Money Flow: 1069511 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.78 - 0.94) Sell
Bollinger Bands (100): (0.89 - 1.21) Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 114.3 Sell
20-day SMA: 116.22 Sell
50-day SMA: 125.51 Sell
200-day SMA: 128.16 Sell
8-day EMA: 114.13 Sell
20-day EMA: 117.02 Sell
50-day EMA: 122.76 Sell
200-day EMA: 123.17 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.76 Sell
20-day SMA: 0.84 Sell
50-day SMA: 0.99 Sell
200-day SMA: 1.13 Sell
8-day EMA: 0.75 Sell
20-day EMA: 0.83 Sell
50-day EMA: 0.94 Sell
200-day EMA: 1.04 Sell

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.79 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):